跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Trilacgen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Trilacgen
Approved
STANDARD
Trilacgen
Reyoung Pharmaceutical Co. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
12ea9ca07c1321d8
Company
Reyoung Pharmaceutical Co. Ltd.
Type
Standard
Approval Details
Approval Id
12ea9ca07c1321d8
Drug Approval Philippines Name
Trilacgen
Product Name
Trilacgen
Registration Number
DRP-11080-02
Brand Name
Trilacgen
Generic Name
Ceftriaxone (as Sodium) + Sulbactam (As Sodium)
Dosage Form
Powder for Injection (IM/IV)
Dosage Strength
1g/500mg
Manufacturer
Reyoung Pharmaceutical Co. Ltd.
Importer
Medinova Pharmaceutical Inc
Distributor
GA2 Pharmaceutical Inc.
Issuance Date
24 June 2022
Expiry Date
26 January 2027
Pharmacologic Category
Antibacterial (Cephalosporin/Beta-lactamase Inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
12ea9ca07c1321d8
Type
Standard
Back to Philippines FDA Approvals